C9 and age-related macular degeneration: Geerlings et al. measured the serum C9 levels of ~90 individuals carrying the P167S rare genetic variant and demonstrated individuals with the P167S had higher average serum C9 levels (10.7 μg/ml) than controls with (6.6 μg/ml) or without (6.1 μg/ml) AMD.